A device composed of a poly (N-isopropylacrylamide)-co-acrylic acid (pNIPAm-co-AAc) microgel layer sandwiched between two thin Au layers (all on a glass support) was used as a novel platform for controlled and triggered small molecule delivery. Tris (4-(dimethylamino)phenyl)methylium chloride (Crystal Violet, CV), which is positively charged, was loaded into the microgel layer of the device and released in a pH dependent fashion, at a rate that could be controlled by the thickness of the Au layer coating the microgels. Specifically, at pH 6.5 (above the pKa for AAc) the microgels were negatively charged, promoting the strong interaction between the CV and the microgels, hindering its release from the layer. At pH 3.0 the microgel's AAc groups are protonated making the microgel mostly neutral, allowing CV to be released from the microgel layer at a rate that depends on the thickness of the Au covering the microgels. Specifically, devices with thin Au overlayers on the microgel layer allow CV to be released from the device faster than devices with thick Au overlayers. The ability to tune the release rate with pH and Au layer thickness is advantageous for developing implantable devices that are capable of releasing small molecule drugs in a triggered and controlled fashion.
The main elementary
processes were identified during simultaneous
crystallization of NaCl and KCl from aqueous solutions by the batchwise
evaporative method using NaCl seeds. In the early stages of the batch
operation, when only NaCl crystallizes, the main elementary processes
are molecular crystal growth, agglomeration, and secondary nucleation.
When the eutonic condition is exceeded, a KCl primary nucleation event
takes place in solution. Subsequently, part of the resulting KCl particles
agglomerate with the NaCl particles. Besides, epitaxial growth of
KCl upon NaCl crystals takes place. Consequently, the product is comprised
of mixed composition polycrystalline particles and single crystals
of each salt. The elementary phenomena just described were sensitive
to crystallization conditions such as evaporation rate, seed size,
and seed content, suggesting the possibility of controlling the morphological
features of the particulate product as well as the chemical composition
of its size fractions. Such knowledge is important in the context
of wastewater treatment, where the particulate product should be suitable
either for disposal as a residue or for further processing in easily
separable size fractions for exploitation of valuable components.
To
meet contemporary industry needs, saline wastewater treatment
with zero liquid discharge goals is gaining increasing attention.
In this context, evaporative crystallization has been applied to simultaneously
remove all dissolved compounds as a solid residue. By conducting simultaneous
crystallization in a way that the components crystallize as single
particles, their downstream separation as products is made simple,
so that no solid waste is generated. We have recently identified the
main phenomena that control particle morphology for batchwise simultaneous
crystallization in the NaCl–KCl–H2O model
system seeded with NaCl. In this work, a process strategy is proposed,
wherein crystallization elementary phenomena are tuned by seeding
with KCl particles. Formation of multicomponent particles was inhibited
with a small seed surface area, because the epitaxial growth of NaCl
upon the KCl seeds was hampered. By a proper choice of seeding policy,
the product may be classified into large particles rich in KCl (purity
higher than 90 wt %) and smaller particles rich in NaCl (∼75
wt %). Secondary nucleation and epitaxial growth of NaCl on KCl were
the main hindrances to the formation of pure populations of each compound.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.